Cargando…
Pfizer-BioNTech mRNA Vaccine Protection among Children and Adolescents Aged 12–17 Years against COVID-19 Infection in Qatar
Qatar was also hit hard by the global pandemic of SARS-CoV-2, with the original virus, Alpha variant, Beta variant, Omicron BA.1 and BA.2 variants, Omicron BA.4 and BA.5 variants, and Delta variant, sequentially. The two-dose primary series of BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine against SARS...
Autores principales: | Osman, Khadieja, Mundodan, Jesha, Chowdhury, Juel, Ravi, Rejoice, Baaboura, Rekayahouda, Albuquerque, Jeevan, Riaz, Bilal, Emran, Reem Yusuf, Batoul, Khatija, Esameldin, Abdul Mahmood, Al Tabatabaee, Zinah, Khogali, Hayat, Albayat, Soha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610824/ https://www.ncbi.nlm.nih.gov/pubmed/37896926 http://dx.doi.org/10.3390/vaccines11101522 |
Ejemplares similares
-
Key Lessons from COVID-19: A Narrative Review Describing Qatar’s Multifactorial Approach in Executing a Vaccination Campaign
por: Albayat, Soha, et al.
Publicado: (2023) -
Bordetella pertussis: An agent not to be forgotten in Qatar
por: Hasnain, Samina, et al.
Publicado: (2021) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021) -
Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021) -
Pfizer-BioNTech COVID-19 vaccine safe in children
Publicado: (2022)